News and blogs
404 results found.
Blood cancer survivor from Blaydon runs for Grandad.
Civil servant, Ben Henderson from Blaydon took on the iconic Great North Run in support of Blood Cancer UK. He’s running in memory of his beloved grandad, Ian, who died earlier this year following a fight with blood cancer.
Survival in people with myeloma nearly doubles since 2005
People diagnosed the blood cancer - myeloma - are now living nearly twice as long on average as they were in 2005.
Beating blood cancer: It takes support
More than 2,500 people reached out to us for support in the last year. We're here for everyone who needs our help.
Beating blood cancer: It takes research
Every world-first treatment and life saved takes huge collective endeavour. Dr Richard Francis tells us how research is getting us closer and closer to beating blood cancer.
Beating blood cancer: It takes action
We want the voice of our community to be heard – to make it impossible for people in power to ignore the changes that are needed.
Beating blood cancer: It takes a community
You’re a crucial part of spreading the word this Blood Cancer Awareness Month
Bodenham Arboretum owners personal cause to support
James and Wendy Binnian’s commitment to the blood cancer research, which is the fifth most common cancer cause in the UK, is deeply personal.
Fairer access to vital tests required as Goverment expand community diagnostic centres
Blood Cancer UK welcomes the expansion of out-of-hours appointments at Community Diagnostic Centres but says more must be done to tackle regional variation and speed up testing, with blood cancer survival falling behind those of similar countries.
Legislation to speed up cutting-edge blood cancer treatments comes into play
In a world first, Medicines and Healthcare products Regulatory Agency (MHRA) introduced regulations that will allow personalised medicines to be prepared in small or individual batches, bringing care closer to the patient.
Acceleration through strategy and science: highlights from our 2025 Research Symposium
In July, 120 leading blood cancer researchers and partners gathered for Blood Cancer UK’s Research Symposium at the Royal College of Physicians. With 14 presentations on 7 different blood cancers, researchers shared bold ideas and their latest progress a
What does the 10 Year Health Plan mean for people with blood cancer?
The Government wants to deliver three key shifts to make the NHS fit for the future. So, what does the published plan mean for the blood cancer community?
We've come so far but we're not done yet: accelerating research progress
Blood Cancer UK are accelerating progress through research and will invest £70m in the next five years.
Manchester researcher awarded £300k as Blood Cancer UK launches £70 million strategy
A researcher at the University of Manchester has been awarded a 3-year research fellowship as Blood Cancer UK launches a bold new strategy to invest £70 million in life-saving research over the next five years.
Cambridge researchers awarded £700k as charity launches £70 million strategy to beat blood cancer
Researchers at the University of Cambridge have been awarded two research fellowships as Blood Cancer UK launches a bold new strategy to invest £70 million in life-saving research over the next five years.
Blood Cancer UK's response to the 10 year health plan
Blood Cancer UK welcome the Government’s 10 Year Health Plan and recognition that strategic change is needed to address the challenges facing the NHS.
Zanubrutinib (Brukinsa®) approved for mantle cell lymphoma
Zanubrutinib (Brukinsa®) has been approved as a treatment option for relapsed or refractory mantle cell lymphoma (MCL) in those who have received at least one prior therapy. Around 500 people in the UK are diagnosed with mantle cell lymphoma each year.
Interferon for MPNs - Pegasys available from July
Pegylated interferon alfa 2a (Pegasys), used to treat MPNs, should be back in supply from July 2025, after production has started at a new UK site.
Harnessing the power of T-cells in stem cell transplants
Stem cell transplants can be a life-saving treatment for people with myeloma, a type of blood cancer that can be treated but currently has no cure. Dr Dimeloe tells us how she is harnessing the power of T-cells in her research.
Clinical trial boost with app upgrade
Blood Cancer UK react to the news that the NHS app will now allow people to sign up to clinical trials.
Patients on NHS are first in the world to access new myeloma drug
Around 3,600 patients across England and Wales every year will now be eligible for this treatment combination.
